Mineralys Therapeutics CEO Jon Congleton's 2023 pay jumps 208% to $5.4M
Mineralys Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 9, 2024
Mineralys Therapeutics reported fiscal year 2023 executive compensation information on April 9, 2024.
In 2023, three executives at Mineralys Therapeutics received on average a compensation package of $3.3M, a 156% increase compared to previous year.
Average pay of disclosed executives at Mineralys Therapeutics
Jon Congleton, Chief Executive Officer, received $5.4M in total, which increased by 208% compared to 2022. 86% of Congleton's compensation, or $4.6M, was in option awards. Congleton also received $246K in non-equity incentive plan, $517K in salary, as well as $13K in other compensation.
David Rodman, Chief Medical Officer, received a compensation package of $2.3M, which increased by 112% compared to previous year. 69% of the compensation package, or $1.6M, was in option awards.
Adam Levy, Chief Financial Officer, earned $2.2M in 2023, a 115% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 9, 2024.